59 results
Page 3 of 3
8-K
EX-10.1
2l3tc sxgx
25 Sep 18
Entry into a Material Definitive Agreement
8:01am
8-K
EX-2.1
sbvqhd8xqj xse82fw
25 Sep 18
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
q9xk4jmaeoclg
30 Dec 13
Amicus Therapeutics Completes Debt
12:00am
8-K
EX-10.2
o8hcv4ya0rsy52r29
21 Nov 13
Callidus Biopharma Acquisition Adds Next-Generation Pompe ERT and Enzyme Technology Platform
12:00am
8-K
EX-10.2
v2gj430m7 oy1
18 Apr 11
Amicus Therapeutics Announces Transition of John F. Crowley from Chairman and Chief Executive Officer to Executive Chairman
12:00am
8-K
EX-4.1
bm8lqe67m153k8
26 Feb 10
Amicus Therapeutics Announces $18.5 Million Registered Direct Offering of Common Stock
12:00am
8-K
EX-10.1
jflr3drscwqcw7
26 Feb 10
Amicus Therapeutics Announces $18.5 Million Registered Direct Offering of Common Stock
12:00am
8-K
EX-10.2
2dk52hyab17m h3v
26 Feb 10
Amicus Therapeutics Announces $18.5 Million Registered Direct Offering of Common Stock
12:00am
S-1
EX-10.3
g6h1ec8
17 May 06
IPO registration
12:00am